Overview

Safety of Bosentan in Type II Diabetic Patients

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study evaluates the safety of topical Bosentan in Type II Diabetes patients
Phase:
Phase 1
Details
Lead Sponsor:
Retinset SL
Collaborator:
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Treatments:
Bosentan